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Abstract
In order to begin to study the structural and functional mechanisms of olfactory receptors, methods for milligram-scale
purification are required. Here we demonstrate the production and expression of a synthetically engineered human
olfactory receptor hOR17-4 gene in a stable tetracycline-inducible mammalian cell line (HEK293S). The olfactory receptor
gene was fabricated from scratch using PCR-based gene-assembly, which facilitated codon optimization and attachment of
a 9-residue bovine rhodopsin affinity tag for detection and purification. Induction of adherent cultures with tetracycline
together with sodium butyrate led to hOR17-4 expression levels of ,30 mg per 150 mm tissue culture plate. Fos-choline-
based detergents proved highly capable of extracting the receptors, and fos-choline-14 (N-tetradecylphosphocholine) was
selected for optimal solubilization and subsequent purification. Analysis by SDS-PAGE revealed both monomeric and
dimeric receptor forms, as well as higher MW oligomeric species. A two-step purification method of immunoaffinity and size
exclusion chromatography was optimized which enabled 0.13 milligrams of hOR17-4 monomer to be obtained at .90%
purity. This high purity of hOR17-4 is not only suitable for secondary structural and functional analyses but also for
subsequent crystallization trials. Thus, this system demonstrates the feasibility of purifying milligram quantities of the GPCR
membrane protein hOR17-4 for fabrication of olfactory receptor-based bionic sensing device.
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Introduction
Membrane proteins areofvitalimportancetolife,asevidenced by
the fact that ,30% of the genes in almost all sequenced genomes
code for membrane proteins [1–3]. However, our understanding of
thestructuresandfunctionsofmembraneproteinshaslaggedbehind
the known soluble proteins. As of June 2008, there are only 160
unique membrane protein structures known [http://blanco.biomol.
uci.edu/Membrane_Proteins_xtal.html], which constitutes less than
1% of all known protein structures. The major bottleneck in
obtaining membrane protein structures is the notorious difficulty
involved in expressing and purifying the large quantities of
membrane protein sample required for X-ray crystallography. In
order to accelerate membrane protein structural and function
studies, simple and reliable methods for membrane protein
production must be developed.
Olfactory receptors (or odorant receptors) are an extremely large
class of G-Protein Coupled Receptors (GPCRs) that function
together combinatorially to allow discrimination between a wide
range of volatile molecules [4,5]. All GPCRs are integral
membrane proteins with seven transmembrane domains arranged
in a barrel-like conformation. In olfactory receptors, it is believed
that this configuration forms a funnel-shaped pocket for odorant
recognition [6]. The olfactory receptor (OR) gene family
constitutes the largest single class of genes in the vertebrate genome
(2–3% in the human). Current estimates put the number of human
olfactory receptor genes at 636, with only 339 being functional and
the rest being non-functional pseudogenes [7]. This is considerably
less than the mouse OR gene family of 1209 (913 functional) [8] or
the canine OR gene family of roughly 1200 (,1000 functional) [9].
Despite the fact that they represent the largest class of known
membrane proteins, no detailed structure exists for any olfactory
receptor and the functional mechanisms of these amazing receptors
remains unknown. The crucial first step to enable such pivotal
studies is to engineer systems with the capacity to generate and
purify milligram quantities of an olfactory receptor.
Mammalian olfactory receptors are expressed on the cilia of
olfactory neurons within the nasal cavity. Odorant binding and
recognition leads to activation and release of the olfactory G-protein
Golf, which triggers cyclic-AMP production, ion-channel-mediated
Ca2+ influx, and finally the firing of an action potential into the
olfactory bulb to be interpreted by the brain [10]. Through an
unknown mechanism of allelic inactivation, every olfactory neuron
chooses a single OR gene to express. Signals from neurons that
express the same olfactory receptor later converge downstream at
neural foci called glomeruli [11]. As the same odorant will stimulate
multiple ORs (and to various strengths), the brain receives a spatial
map of receptor activity through these glomeruli [12]. Odorants are
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combinatorial code) [5].
The human olfactory receptor 17-4 (hOR17-4, alternately known
as OR1D2) is of particular interest since, in addition to olfactory
neurons, it is also expressed on the midpiece of human spermatozoa
[13]. Sperm expressing hOR17-4 were found to migrate towards
known hOR17-4-responsive odorants such as bourgeonal. Thus the
receptor serves a dual role in that it recognizes odorants in the nose
as well as plays a potential roleinsperm chemotaxis and fertilization.
As structural studies of hOR17-4 would not only provide
information crucial to understanding the molecular mechanism(s)
of olfaction but also have application to human reproduction and
population control, we thus selected this receptor as our prototype
OR for expression and purification trials.
The GPCR family represents one of the most important known
receptor classes as evidenced by the fact that half of all
pharmaceutical drugs target GPCRs [14]. Despite their crucial
role in mediating such diverse physiological processes as sight,
smell, and the response to hormones and neurotransmitters,
extremely little is known about these receptors at the structural
level. A major breakthrough in 2007 was the determination of only
the second GPCR crystal structure–that of a highly engineered
human beta2-adrenergic receptor expressed in Sf9 insect cells
where intracellular loop 3 was replaced with either antibody or T4
lysozyme to facilitate crystallization [15,16]. Rhodopsin is perhaps
the only GPCR that can be easily extracted from tissue, and this
may explain why it was the first GPCR to have a detailed structure
determined [17–19]. However, recent advances in the Khorana
laboratory have led to the development of specific mammalian
HEK293 cell lines for heterologous expression as well as methods
for purification that yield milligram quantities of functional
rhodopsin which is suitable for functional analysis and structural
study [20–22]. We recently used same rho1D4-tag system for a
one-step affinity purification of the human tetraspanin membrane
protein CD81 [23]. Here we show that this system can be also
adapted to facilitate the production and purification of another
GPCR, the human olfactory receptor 17-4.
In order to carry out biochemical and structural analyses of
olfactory receptors as well as engineer olfactory receptor-based
biosensor devices, large quantities of receptors are required. Here
we here report inducible expression, large-scale production of
human olfactory receptor hOR17-4. We bioengineered the
synthetic hOR17-4 gene into 50 oligonucleotide fragments, self-
assembled them through high cycle PCR and inserted the
assembled gene into an inducible human embryonic kidney cell
line (HEK293S). We then induced its production using a
combination of tetracycline and sodium butyrate. After systematic
detergent screening, the zwitterionic detergent fos-choline-14
(FC14) was found to be most effective for solubilization and was
subsequently used throughout the entire solubilization and
purification. To our knowledge this is the first time an olfactory
receptor has been purified from a mammalian cell line.
Results
Construction of synthetic hOR17-4-rho gene
To fabricate synthetic gene constructs we utilized a PCR-based
method of gene synthesis [24] that involves parsing the DNA
sequence into a set of small overlapping oligonucleotides. During
an initial assembly PCR, these oligos function as both primer and
template, while the DNA polymerase successively builds longer
and longer fragments with each round of PCR. A second
amplification PCR then enriches for the full-length gene (Figure
S1). This process has more recently become known as PCA, or
polymerase construction and amplification. To assist in parsing the
sequence into oligos (Figure S2), we used the online program
DNAWorks (http://helixweb.nih.gov/dnaworks) developed by
Hoover and Lubkowski [25].
The 312 amino acid sequence of wild-type human olfactory
receptor hOR17-4 was obtained from GenBank and directly
inputted into the software in protein mode. To adapt the resulting
gene for use in our specific expression system and to facilitate
purification and detection, the reverse-translated DNA sequence was
human codon-optimized and appended with a C-terminal rho1D4
epitope tag (TETSQVAPA) [20–22]. The synthetic DNA corre-
sponding to the hOR17-4 gene consisted of 1004 bp, encoding a
receptor protein of 323 amino acids (Figure 1). Other than the
addition of the rho1D4 tag and linker, the hOR17-4 protein
sequence is wild type and completely full length. Noteworthy in the
synthesis procedure was the requirement for a high number of PCR
cycles(45)duringtheassemblyPCR,presumablyduetoinefficiencies
resulting from non-productive oligonucleotide mispairings.
Induction of hOR17-4 expression in stable HEK293S cell
lines
To minimize the toxic effects of receptor overexpression, stable
hOR17-4-inducible HEK293S cell lines were created using the
Invitrogen T-REx tetracycline regulation system (Materials and
Methods). This allowed large-scale cell culture batches to be
grown and then, when desired, concerted production of fresh
olfactory receptor to be induced in nearly 100% of the cells.
Results for the induction of hOR17-4 expression in two of the
subcloned HEK293 lines are shown in Figure 2A. Western
immunoblotting using a monoclonal antibody against the rho1D4
tag revealed major immunoreactive bands at approximately 32 kD
and 60 kD, which correspond in size to monomeric and dimeric
forms of the hOR17-4 receptor. This size pattern has been
reported previously for several solubilized olfactory receptors
expressed in Sf9 and mammalian cells [26–28]. Larger molecular
weight complexes were also present, presumably due to aggrega-
tion and precipitation of the receptor. As sample boiling only
increases the precipitation, it is possible that increased tempera-
tures (above 4uC) caused by the electrophoresis could be causing
the receptor to partially aggregate. Thus these high MW species
could be a side effect of the SDS-PAGE electrophoresis and not
originally present in the solubilized receptor fractions.
The histone deacetlyase inhibitor sodium butyrate has been
demonstrated to synergistically enhance expression when used
with tetracycline-regulated systems [21]. Induction of hOR17-4 in
HEK293S cells using tetracycline in conjunction with sodium
butyrate increased expression by approximately 4–5 fold over
tetracycline alone at all time points tested (Figure 2B). There was
no detectable expression of hOR17-4 in the absence of tetracycline
or with sodium butyrate alone. Significant cell toxicity and death
was observed in treatments combining tetracycline and sodium
butyrate (5 mM) at the 48 and 72 hours time points. Treatment
with sodium butyrate or tetracycline alone did not show this
toxicity, indicating it to be a result of the high level expression
induced by the drugs in conjunction.
To characterizethis effectthe samples were subjected SDS-PAGE
analysis (Figure 3A). The gel showed two monomer band sizes,
approximately 30 kD and 32 kD, suggesting distinct monomer
forms (and corresponding dimer forms). It is possible these size
discrepancies are due to differences in glycosylation of the receptor.
Sodium butyrate addition for 24 hours showed a very large increase
in expression over tetracycline alone, with the monomer band
running at approximately 32 kD. Sodium butyrate addition for
longer periods further increased total expression, however this
Study Human Olfactory Receptor
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30 kD. The 48-hour time point contained roughly equal parts of
both forms while the 72-hour time point consisted predominantly of
the 30 kD form. To attempt to avoid the aforementioned toxicity we
next performed a time course using a range of sodium butyrate
concentrations (Figure 3B). We discovered that high levels of
expression appeared to correlate with the appearance of the 30 kD
form (and correspondingly smaller dimer form) and the observed
cytotoxicity noted previously.
For subsequent purification experiments, we selected a
treatment consisting of sodium butyrate (1 mM) with tetracycline
(1 mg/ml) for 48 hours for attempts to purify primarily the 32 kD
form. However, to further compare and characterize both forms,
increasing the sodium butyrate concentration to 5 mM could be
used, as relatively equal amounts of both monomer forms would
be present.
Purification of heterologously expressed hOR17-4
We incorporated a C-terminal rho1D4-tag utilized by the
Khorana lab for rhodopsin purification and detection [20–22],
namely the nine C-terminal amino acid sequence (TETSQVAPA)
against which a specific monoclonal antibody has been generated
(rho1D4). This tag has already facilitated early-stage immunoaffi-
nity purifications of several GPCR membrane proteins [29–32].
For the initial immunoaffinity purification, we used CNBr-
activated Sepharose 4B beads linked to the mouse monoclonal
rho1D4 antibody to capture detergent solubilized receptors [21].
We first performed a small-scale purification from six 150 mm
culture plates of hOR17-4-inducible HEK293S cells. The plates
were treated as to have equal amounts of the 30 kD and 32 kD
bands upon harvesting (tetracycline plus 5 mM sodium butyrate,
48 hours after induction). Following a thorough wash procedure to
remove non-specific impurities, the bound receptors were eluted
by the addition of an excess of epitope peptide (TETSQVAPA).
Fractions were subjected to SDS-PAGE followed by either western
immunoblotting (Figure 4A) or total protein staining using highly-
sensitive SYPRO-Ruby (Figure 4B). The receptor was completely
captured by the bead matrix, as no hOR17-4 was detected in the
flow through by western blot. The bound OR eluted primarily in
the first and second elution fractions. Total yield of hOR17-4 was
approximately 30 mg per 150 mm plate. Mass spectrometry
analysis on samples isolated from SDS-PAGE gel bands confirmed
the identity of putative monomer and dimer protein bands as
hOR17-4 receptor (see Materials and Methods).
Figure 1. Codon-optimized hOR17-4 sequence. The DNA (A) and corresponding amino acid (B) sequence of synthetic hOR17-4 olfactory
receptor gene. The DNA sequence was human codon-optimized and a mammalian Kozak ribosome binding site introduced upstream of the
translation start site. Translation start and stop sites as well as restriction cloning sites are indicated. The engineered construct also contains aC -
terminal tag (underlined) consisting of a glycine linker followed by a nonapeptide epitope for the monoclonal rho1D4 antibody.
doi:10.1371/journal.pone.0002920.g001
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culture plates of hOR17-4-inducible HEK293S cells were used. The
plates were treated tetracycline plus 5 mM sodium butyrate,
48 hours). The total yield of hOR17-4 following immunoaffinity
purificationwas1.5 milligrams.Tofurtherpurifythereceptorandto
remove the elution peptide, the hOR17-4 was subjected to size
exclusion chromatography (SEC) using a gel filtration column on an
A ¨kta HPLC system. Column flowthrough was monitored by UV
absorption (280 nm and 215 nm) and separated into fractions by an
auto-fraction collector. As seen in Figure 5A, five distinct peaks were
observed. The peak fractions were then pooled, concentrated and
subjected to SDS-PAGE followed by total protein staining. As seen
in Figure 5B, peak 3 contains monomeric hOR17-4 (.90% purity)
while earlier peaks contained largely dimeric (peak 2) and
aggregated/oligomerized (peak 1) forms. Peak 4 showed no visible
protein and peak 5 corresponds to the residual elution peptide
Figure 2. Induction of hOR17-4 in stable HEK293S cell lines. A) Stable inducible cell lines were generated in HEK293S cells using the T-REx
system (Invitrogen) expressing hOR17-4 tagged with the rho1D4 tag (TETSQVAPA) at the C-terminus. The pooled cells were then subcloned,
expanded, and then tested for induction in media supplemented with (+) or without (2)1mg/ml tetracycline for 48 hours. Levels of hOR17-4 were
probed via SDS-PAGE western blotting using the rho1D4 antibody. Clones 1 and 5 showed the highest levels of induction while maintaining
undetectable background levels in the absence of tetracycline. Clone 5 was selected for all subsequent experiements. B) Addition of sodium butyrate
enhances induced expression of hOR17-4. Inducible HEK293 was subjected to a dosage time course using the indicated concentrations of tetracycline
and sodium butyrate. Samples were harvested, subjected to dot blot analysis (western blot against rho1D4), and the results quantified by spot
densitometry. Tetracycline in conjunction with sodium butyrate increased expression by approximately 4–5 fold over tetracycline alone at all time
points tested. Tetracycline was necessary to cause induction, as no expression was detected if sodium butyrate was used alone. Additionally,
increasing tetracycline concentration to 2 mg/ml had no significant effect on induction levels.
doi:10.1371/journal.pone.0002920.g002
Figure 3. High-level induction correlates with a band shift of hOR17-4. A) Time point samples (from Figure 2) were normalized to total
protein content and subjected to SDS-PAGE western blotting against rho1D4. All lanes were treated with 1 mg/ml tetracycline with (+) or without (2)
sodium butyrate (5 mM) for the time indicated. B) hOR17-4-inducible HEK293S cells were subjected to a dosage time course using the indicated
concentrations of sodium butyrate. All samples were co-treated with 1 mg/ml tetracycline. Samples were normalized to total protein content and
subjected to SDS-PAGE western blotting against rho1D4.
doi:10.1371/journal.pone.0002920.g003
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yield of purified hOR17-4 monomer was 0.13 milligrams (2.6 mg
per plate). Thus, using a two-step procedure we have successfully
obtained significant amounts of hOR17-4 in a highly pure form.
Discussion
In this study, we successfully developed methods for the
construction of inducible mammalian cell lines that generate large
quantities of olfactory receptor on demand. To our knowledge this
is the first olfactory receptor to be purified from a mammalian cell
line. Currently, we have demonstrated the production of the
human olfactory receptor hOR17-4 in a stable tetracycline-
inducible human embryonic kidney cell line (HEK293S). Ex-
pressed OR genes were fabricated from scratch using PCR-based
gene synthesis (polymerase construction and amplification, aka
PCA), which facilitated codon optimization for high level
expression and attachment of affinity tags for detection and
purification. The HEK293S cells can be grown and OR
expression induced in adherent cultures (yield of ,30 micro-
grams/150-mm plate). Using methods originally adapted from the
production and purification of the bovine GPCR rhodopsin [20–
22] and further optimized (including the full-spectrum screening of
over 70 detergents), the olfactory receptor is solubilized and
extracted from the cells using fos-choline-14. The OR protein is
then isolated using a two-step purification method (immunoaffinity
followed by size-exclusion chromatography) which yields hOR17-
4 monomer at greater than 90% purity (Figure 5B).
There have been a host of previous studies that have expressed
and studied olfactory receptors in native and heterologous systems.
Figure 4. Immunoaffinity purification of hOR17-4. Six 150 mm tissue culture plates of were grown to 90% confluence then induced and treated
with tetracycline (1 mg/ml) and sodium butyrate (5 mM) for 48 hours. Plates were scrape harvested, solubilized, and the processed lysate subjected to
immunoaffinity purification using rho1D4 antibody linked to sepharose beads for capture. Bound proteins were washed and then eluted using the
nonapeptide TETSQVAPA. Samples were subjected to SDS-PAGE followed by either western immunoblotting with rho1D4 antibody (A) or total protein
staining with Sypro Ruby (B). Black triangles indicate the 30 and 32 kD monomer forms. Tot, total lysate; FT, flow through; W, wash; E, elution.
doi:10.1371/journal.pone.0002920.g004
Figure 5. Full purification of hOR17-4 extracted from 506150 mm culture plates. A) Size exclusion chromatography (SEC) on
immunoaffinity-purified hOR17-4. Absorbance was simultaneously recorded at 280 nm (black line, values on left axis) and 215 nm (grey line, values
on right axis). The peaks indicated by numbers were pooled and concentrated. Peak 5 consists of the elution nonapeptide from the immunoaffinity
purification. B) Total protein staining of SEC peak fractions. Load is the original immunoaffinity purified sample applied to the chromatography
column. Peak numbers refer to those designated in (A). Peak 3 contains monomeric hOR17-4 at .90% purity. Total monomer yield was 2.6 mg per
150 mm culture plate.
doi:10.1371/journal.pone.0002920.g005
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have been overexpressed and purified to homogeneity in significant
quantities.WhilepurificationofORshasbeenattemptedinbacterial
[33] and Sf9 insect systems [26–27], these were unable to produce
large quantities of native full-length olfactory receptor. Additionally,
these organisms lack mammalian post-translational machinery and
thus purified receptors may be improperly folded or missing critical
modifications. It is known that most, if not all, GPCRs are
glycosylated, and indeed the olfactory receptors have conserved N-
linked glycosylation sites (Asn-X-Ser/Thr) at their N-terminus [34–
35]. Several studies have indicated that loss of glycosylation can lead
to improper folding and targeting, resulting in decreased function
and compromised structure [36–37]. Loss of either N-terminal
glycosylation site (Asn-2 or Asn-15) of rhodopsin is sufficient to cause
loss of signal transduction despite no apparent change in localization
or folding [38–39]. This indicates that purification of olfactory
receptors from mammalian systems might be crucial for functional
expression and purification.
Characterization of purified hOR17-4
It is interesting to note that the engineered hOR17-4-rho protein
(with theoretical molecular mass of 36.2 kD) migrates slightly faster
than expected on SDS-PAGE gels (30 kD and 32 kD). One
possible explanation for this discrepancy is incomplete receptor
denaturation by SDS since boiling the samples results in
aggregation. Indeed, many other membrane proteins have been
found to migrate faster than their actual size on SDS-PAGE, and
this has been reported for other olfactory receptors as well [27,33].
We believe both monomer forms of the expressed hOR17-4
receptor to be intact, full-length proteins as evidenced by: 1)
detection by the C-terminal rho1D4 monoclonal antibody, 2)
detection by custom anti-hOR17-4 polyclonal antibodies raised
against the hOR17-4 N-terminus or C-terminus, 3) detection of a
30 kD N-terminally 6xHis-tagged hOR17-4 variant using anti-His
antibodies (data not shown). Additionally, we see only the 32 kD
form at low levels of induction while the 30 kD form only begins to
appear at higher levels of induction. One explanation is that the
receptor is glycosylated at low induction but that the toxicity
associated with higher expression causes the receptor to begin to
accumulate in the ER and not be properly processed.
The appearance of two distinct hOR17-4 monomer bands
following purification could pose a problem for structural studies
using X-ray crystallography, since typically a high degree of
protein homogeneity is required for protein crystallization. We
initially believed that it was possible to obtain primarily 32 kD
form using lower levels of induction (Figure 3B). However, we
have observed that the rho1D4 immunoaffinity purification
appears to increase the proportion of 30 kD monomer form
relative to 32 kD form given the original treatment. For example,
the treatment dosages for the small-scale (Figure 4) and large-scale
(Figure 5) purifications were chosen (based on data in Figure 3B) to
result in equal amounts of both forms or primarily 32 kD form,
respectively. However, following immunoaffinity purification the
resulting elution samples were enriched in the 30 kD monomer
form. One hypothesis is that the 30 kD (potentially non-
glycosylated form) binds more readily to the rho1D4-coupled
bead matrix. Therefore, to obtain truly homogeneous hOR17-4
monomer it might be necessary to use even lower levels of
induction where no 30 kD form exists. Another option would be to
mutate the asparagine in the consensus N-glycosylation site of the
receptor, located at amino acid position 5. We predict such a
change to result in exclusive production of the 30 kD monomer
form. However, the functional effect of abolishing glycosylation on
the receptor is unknown.
There have been numerous reports in the literature citing
difficulties in expressing functional olfactory receptors in heterol-
ogous systems. The main problem seems to be improper
membrane targeting and resulting cytosolic localization of the
majority of ORs [35–36,40–41]. Several studies have been able to
alleviate this problem by the addition of putative membrane
import signals to the N-terminus of the olfactory receptor [42–43].
However, more recent studies [44–45] have expressed functional
olfactory receptors in HEK293 cells without the use of such signal
tags. We also investigated the use of an N-terminal ‘‘membrane
import’’ sequence composed of the first twenty amino acids of
bovine rhodopsin but found no significant increase in receptor
yield or localization (results not shown).
Our largest adherent culture experiment consisted of fifty
150 mm tissue culture plates. While the total yield of crude
hOR17-4 following immunoaffinity purification was 1.5 milli-
grams, the subsequent size exclusion chromatography and
associated concentration steps reduced this yield to 0.13 milli-
grams of purified hOR17-4 monomer (2.6 mg per plate). The
monomer was .90% pure, with the only other major contam-
inating band consisting of hOR17-4 dimer. While this represents a
significant milestone, using adherent culture for milligram-scale
purification of the receptor monomer poses a substantial
challenge. However, the HEK293S cell line is capable of
suspension culture, and we plan to scale-up purification yields by
adapting the system to culture in a large volume (5–10 liter) liquid
bioreactor. The high cell densities allowed should allow the
production and subsequent purification of milligram quantities of
olfactory receptors, which will be necessary for future experiments
in determining receptor structure and function.
General application for the purification of other olfactory
receptors
Here we show that a GPCR olfactory receptor gene can be
designed, synthesized, placed into an inducible mammalian
expression system and the resulting full-length protein purified to
near homogeneity in a two-step process. In addition to our
experiments on hOR17-4, we have constructed optimized
synthetic genes for several mouse olfactory receptors and initial
expression trials have proven successful. The small size of the
rho1D4 tag and its extremely mild elution conditions provide a
minimum of disruption to the purified protein. In contrast to
previous attempts at OR purification using bacterial systems which
required fusion to GST and truncated or mutated OR protein
sequences [33], the system described here allows for the
production of full-length wild-type OR. The application of this
technique to other olfactory receptors could feasibly lead to a
generalized method for obtaining large quantities of any olfactory
receptor in a rapid and simple manner. Such methods could prove
extremely useful in elucidating the structural and functional
mechanism(s) of olfactory receptors and in their integration into
OR-based bionic sensing devices.
Simple and adaptable methods
Membrane proteins are natural nanobiodevices; they perform
exquisitely fine functions, from specific ion channels, chemical
transporters, signal transduction, and information processing, to
photosynthesis for direct solar energy harvesting. In order to
accelerate determination of membrane protein structural studies,
simple and reliable methods are necessary to attract more and
more researchers to study these elusive membrane proteins and
use them to fabricate new bionic devices. We here show that the
GPCR olfactory receptor gene can be bioengineered, placed into
an inducible system and to purify to near homogeneity in a
Study Human Olfactory Receptor
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very important step not only for us to understand the secret of
smell, but also to design new bionic nose sensing devices.
Materials and Methods
Gene Construction
The protein sequence for hOR17-4 (also known as OR1D2) was
obtained from GenBank (NCBI Accession # NP002539). DNA-
Works online software (http://helixweb.nih.gov/dnaworks) was
used in protein mode to design the synthetic gene and parse it into
an oligonucleotide set. To adapt the synthetic hOR17-4 olfactory
receptor gene for use in mammalian cell expression and
purification, the following sequence modifications were made: i)
human codon optimization; ii) addition of a C-terminal rho1D4
epitope tag (TETSQVAPA) preceded by a two glycine linker to
facilitate detection and purification; iii) addition of a Kozak
consensus sequence (GCCACCACC) immediately 59 to the ATG
start codon; iv) addition of an EcoRI restriction site at the 59 end
and a NotI restriction site at 39 end of the gene to enable cloning
into expression vectors. The synthetic hOR17-4 gene consisted of
1004 bp, of which 969 bp code for the 323 amino acid hOR17-4-
GlyGly-rho1D4 protein. The designed oligonucleotide primers
were purchased from IDT (Coralville, IA) with a maximum length
of 45 bp (Figure S2). PCR-based gene synthesis was performed
using a 2-step assembly/amplification protocol (Figure S1) [46]
with the exception that the assembly PCR was run for 45 cycles.
PCR reactions were then analyzed by gel electrophoresis and
stained with ethidium bromide. Full-length product was excised,
extracted, and then digested with the pertinent restriction
enzymes. The genes were then ligated into the T-REx
pcDNA4/To inducible expression plasmid (Invitrogen, Carlsbad,
CA), sequenced, and a correct clones grown up using a MaxiPrep
kit (Qiagen, Valencia, CA). The plasmid containing the optimized
hOR17-4 gene was designated pcDNA4/To-hOR17-4-rho1D4.
Generation of Stable Inducible Cell Lines
HEK293S (suspension adapted HEK293 cells) containing the
stable expression of pcDNA6/Tr (Invitrogen) which encodes the
Tet repressor protein (TetR) had previously been generated and
cloned [21]. HEK293S cell monolayers were grown in DMEM/
F12 with GlutaMAX (Invitrogen catalog # 10565-042) supple-
mented with fetal bovine serum (10%), HEPES (15 mM), non-
essential amino acids (0.1 mM), sodium pyruvate (0.5 mM),
penicillin (100 units/ml), streptomycin (100 mg/ml) and grown
at 37uCa t5 %C O 2. All tissue culture and media components were
purchased from Invitrogen unless otherwise noted. The pcDNA4/
To-hOR17-4-rho1D4 plasmid was then transfected into these cells
using Lipofectamine 2000 and after 48 hours cells were subjected
to drug selection in 5 mg/ml blasticidin and 250 mg/ml zeocin for
2 weeks and then subcloned. 28 colonies were expanded and
screened for inducible expression using media supplemented with
or without 1 mg/ml tetracycline for 48 hours. Samples were then
scrape harvested, solubilized in phosphate buffered saline (PBS)
with 2% w/v Fos-Choline-14 (Anatrace, Maumee, OH) and
Complete Protease Inhibitor Cocktail (Roche, Basel, CH) for
1 hour at 4uC. Expression was assayed via dot blotting and SDS-
PAGE western blotting using the mouse monoclonal antibody
rho1D4. Clone 5, the colony showing the best expression of
hOR17-4 under induction conditions while maintaining unde-
tectable expression without induction, was selected and expanded
into large-scale culture and used for all subsequent experiments.
The hOR17-4-inducible HEK293S cell line was maintained using
5 mg/ml blasticidin and 250 mg/ml zeocin.
Cell Extract Preparation
Buffers used were as follows: PBS buffer: 137 mM NaCl, 2.7 mM
KCl, 1.8 mM KH2PO4,1 0m MN a 2HPO4 (pH 7.4); Solubilization
buffer: PBS containing Complete Protease Inhibitor Cocktail
(Roche, Basel, Switzerland) and 2% wt/vol FC14; and Wash buffer:
PBS containing 0.2% FC14; Elution buffer: Wash buffer containing
100 mM Ac-TETSQVAPA-CONH2 elution peptide. The detergent
FC14 was purchased from Anatrace (Maumee, OH). Sodium
butyrate was purchased from Sigma (Saint Louis, MO).
For initial dosage and time course experiments, hOR17-4-
inducible HEK293S cells were grown to 80–90% confluency at
37uC in 6-well tissue culture plates, treated as indicated and then
scrape harvested into ice-cold PBS containing Complete Protease
Inhibitor Cocktail. The hOR17-4 was then solubilized by
resuspending the cell pellets in 150 ml solubilization buffer and
rotating for 1 hour at 4uC. The non-solubilized fraction was then
pelleted using at 13,000 g for 30 minutes. The supernatant was
then removed and analyzed by SDS-PAGE.
For purification experiments, up to fifty 150 mm tissue culture
plates were used per experiment. Briefly, hOR17-4-inducible
HEK293S cells were seeded at a density of 5610
6 cells per
150 mm dish and grown for 72 hours at 37uC, at which point they
reached 80–90% confluency. The cells were then induced with
medium containing tetracycline (1 mg/ml) plus sodium butyrate (as
indicated). After 48 hours, the cells were harvested by scraping (at
4uC) each plate into 2 ml PBS containing Complete Protease
Inhibitor Cocktail. The cells were then pooled and snap frozen in
liquid nitrogen and stored at 280uC until purification was carried
out. On the day of purification, cells were thawed on wet ice and
spundownbycentrifugationat4000 gfor1 minute.Allfurthersteps
were performed at 4uC unless noted. The hOR17-4 was then
solubilized by resuspending the cells in solubilization buffer (1–2 ml
per 150 mm plate) and rotating for 4 hours. The non-solubilized
fraction was then pelleted using an ultracentrifuge at .100,000 g for
30 minutes. The resulting supernatant was removed and put at 4uC.
A small amount of supernatant (100 ml) was set aside, labeled ‘‘total
lysate’’ and stored at 220uC. The remainder was directly applied to
immunoaffinity purification.
Immunoblotting and Total Protein Staining
Samples were assayed via polyacrylamide gel electrophoresis
(SDS-PAGE) under both reducing and denaturing conditions.
Samples were prepared and loaded according to standard Novex
gel protocols with the exception that the samples were incubated at
room temperature prior to loading, as boiling caused membrane
protein aggregation. Full Range Rainbow (GE Healthcare,
Waukesha, WI) molecular weight marker was loaded as the
protein size standard. Samples were resolved on Novex 10% Bis-
Tris SDS-PAGE gels (Invitrogen) were run using NuPAGE MOPS
buffer at 100 V and were subsequently transferred to a 0.45 mm
nitrocellulose membrane and subjected to western immunoblot-
ting using the rho1D4 as primary antibody, followed by a
secondary HRP-linked goat anti-mouse IgG (Pierce, Rockford, IL)
and detection using the ECL-Plus Kit (GE Healthcare). For total
protein staining, SDS-PAGE gels were run as above, stained using
SYPRO-Ruby (a more sensitive alternative to Coomassie;
Invitrogen), and visualized by fluorescence using UV transillumi-
nation (excitation wavelength 300 nm). All western blot and
SYPRO-Ruby images were captured using a Fluor Chem gel
documentation system (Alpha Innotech, San Leandro, CA).
Immunoaffinity Purification
For immunoaffinity purification we utilized rho1D4 monoclonal
antibody (Cell Essentials, Cambridge, MA) chemically linked to
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rho1D4 elution peptide Ac-TETSQVAPA-CONH2 was synthe-
sized by CBC Scientific (San Jose, CA). Rho1D4-sepharose
immunoaffinity purification has been described previously [21].
Briefly, the cell extract supernatant was mixed with rho1D4-coupled
sepharose bead slurry (binding capacity 0.7 mg/ml) and rotated
overnight at 4uC to capture the rho1D4-tagged olfactory receptors.
The beads were then pelleted by centrifugation at 2000 g for one
minute and the supernatantcollected, labeled as‘‘flow-through’’ and
saved for future analysis. The beads were then re-suspended in 100
bead volumes of cold wash buffer (PBS+0.2% Fos-Choline-14),
rotated for 10 minutes at 4uC, then re-pelleted. A total of fivewashes
were carried out and 100 ml of each sequential wash was saved for
subsequent analysis. After the final wash, the beads were pelleted
again and transferred to a new tube for elution. A series of five
elutions (each rotated 1 hour at room temperature) was then carried
out, each using 1 bead volume of elution buffer (PBS+0.2%
FC14+100 mM TETSQVAPA peptide). Total protein concentra-
tion was measured using BCA assay (Pierce).
Mass Spectrometry
Immunoaffinity-purified samples of hOR17-4 were separated
via SDS-PAGE, stained with SYPRO-Ruby and gel bands at
30 kD, 32 kD, and 60 kD were excised into sterile, methanol-
rinsed microcentrifuge tubes. The samples subjected to trypsin
digestion and the resulting fragments analyzed by Ion Trap LCMS
for protein identification by the MIT Biopolymers Laboratory
(Cambridge, MA). All bands were identified as hOR17-4,
indicating monomeric and dimeric forms.
Size Exclusion Chromatography
For further purification, hOR17-4 proteins were subjected to gel
filtration chromatography using a HiLoad 16/60 Superdex 200
column on an A ¨kta Purifier HPLC system (GE Healthcare). The
columnwas first equilibratedusing wash buffer(PBS+0.2%w/vFos-
Choline-14). Pooled hOR17-4 elution fractions from the rho1D4
immunoaffinity purification were concentrated to 0.75 mg/ml using
a 10 kD MWCO filter column (Millipore, Billerica, MA) and then
applied to the A ¨kta system. After loading, the column was run with
wash buffer at 1 ml/min and column flowthrough monitored via
UV absorbance at 280 nm and 215 nm. Protein fractions were
collected using an automated fraction collector. Peak fractions were
then pooled, concentrated and subjected to SDS-PAGE and analysis
via Sypro Ruby staining. Total protein concentration was measured
using BCA assay (Pierce).
Supporting Information
Figure S1 PCR-based Gene Synthesis. Fabrication of the
custom hOR17-4-rho gene was accomplished using a two-step
PCR method using an overlapping oligonucleotide set designed
using DNAWorks. (A) The first step is an assembly PCR in which
all oligos function as both primer and template to effectively
extend their 39 ends with successive PCR cycles. After many cycles
of assembly, the full-length gene is constructed. However, the
assembly reaction contains not only full-length product but also a
mixture of all other extended oligos. Thus a second PCR reaction
(B) is performed using a small amount of the assembly PCR
reaction as template and the two terminal oligos (oligos A and L) as
primers in order to selectively amplify the full-length gene product.
Found at: doi:10.1371/journal.pone.0002920.s001 (1.17 MB TIF)
Figure S2 Primers used for the PCR-based synthesis of the
engineered hOR17-4 gene. A total of 50 oligonucleotides were
used to construct the synthetic gene (25 sense strand oligos, labeled
S1-25) and 25 anti-sense strand oligos, labeled AS1-25).
Found at: doi:10.1371/journal.pone.0002920.s002 (0.04 MB
DOC)
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